Turgut Mehmet, Akhaddar Ali, Turgut Ahmet T
Department of Neurosurgery, Aydın Adnan Menderes University Faculty of Medicine, Efeler, Aydın, Turkey.
Department of Neurosurgery, Avicenne Military Hospital of Marrakech, Mohammed V University in Rabat, Rabat, Morocco.
World Neurosurg. 2020 Feb;134:240-263. doi: 10.1016/j.wneu.2019.10.153. Epub 2019 Nov 1.
Calcified or ossified chronic subdural hematoma (CSDH), characterized by slowly progressing neurologic symptoms, is a rarely seen entity that may remain asymptomatic for many years. Management of CSDH has improved dramatically in recent years as a result of advances in diagnostic tools, but there is still some controversy regarding the optimal treatment strategy.
In this systematic review, PRISMA guidelines were followed to query existing online databases between January 1930 and December 2018. We found a total of 88 articles containing 114 cases of calcified or ossified CSDH, comprising 83 patients operated on and 31 not operated on.
In this study, there were 78 males and 29 females (7 with unreported gender) from 25 countries, ages ranging from 4 months to 86 years (mean, 33.7 years), with CSDH caused by head trauma in 33.3%, shunting for hydrocephalus in 27.2%, or after cranial surgery in 4.4%. The duration of symptoms ranged from acute onset to 20 years, with a mean of 24.1 months. Imaging techniques such as radiography, computed tomography, and magnetic resonance imaging were used, with pathologic confirmation of CSDH and complete recovery in 56.4% of patients.
Incidence of calcified or ossified CSDH is high in certain countries, including the United States, Japan, and Turkey, with a steady increase in recent years. The therapy of choice is surgery in these patients and it should be considered in the differential diagnosis at presentation because of its infrequency and variable clinical manifestation, after shunting in children or head trauma in adults.
钙化或骨化性慢性硬膜下血肿(CSDH)以神经症状缓慢进展为特征,是一种罕见的疾病,可能多年无症状。由于诊断工具的进步,近年来CSDH的治疗有了显著改善,但关于最佳治疗策略仍存在一些争议。
在本系统评价中,遵循PRISMA指南查询1930年1月至2018年12月期间现有的在线数据库。我们共找到88篇文章,包含114例钙化或骨化性CSDH病例,其中83例接受了手术,31例未接受手术。
本研究中,来自25个国家的患者有78名男性和29名女性(7名性别未报告),年龄从4个月到86岁(平均33.7岁),CSDH病因包括头部外伤占33.3%,脑积水分流占27.2%,或颅脑手术后占4.4%。症状持续时间从急性发作到20年不等,平均为24.1个月。使用了如X线摄影、计算机断层扫描和磁共振成像等成像技术,56.4%的患者经病理证实为CSDH且完全康复。
钙化或骨化性CSDH在某些国家发病率较高,包括美国、日本和土耳其,近年来呈稳步上升趋势。这些患者的首选治疗方法是手术,由于其发病率低且临床表现多样,在儿童分流后或成人头部外伤后,在就诊时的鉴别诊断中应考虑手术治疗。